Crataegus laevigata Suppresses LPS-Induced Oxidative Stress during Inflammatory Response in Human Keratinocytes by Regulating the MAPKs/AP-1, NFκB, and NFAT Signaling Pathways.
Quynh T N NguyenMinzhe FangMengyang ZhangNhung Quynh DoMinseon KimSheng Dao ZhengEunson HwangTae Hoo YiPublished in: Molecules (Basel, Switzerland) (2021)
Crataegus laevigata belongs to the family Rosaceae, which has been widely investigated for pharmacological effects on the circulatory and digestive systems. However, there is limited understanding about its anti-oxidative stress and anti-inflammatory effects on skin. In this study, 70% ethanol C. laevigata berry extract (CLE) was investigated on lipopolysaccharide (LPS)-stimulated keratinocytes. The LPS-induced overproduction of reactive oxygen species (ROS) was suppressed by the treatment with CLE. In response to ROS induction, the overexpression of inflammatory regulating signaling molecules including mitogen-activated protein kinases (MAPK)/activator protein-1 (AP-1), nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB), and nuclear factor of activated T-cells (NFAT) were reduced in CLE-treated human keratinocytes. Consequently, CLE significantly suppressed the mRNA levels of pro-inflammatory chemokines and interleukins in LPS-stimulated cells. Our results indicated that CLE has protective effects against LPS-induced injury in an in vitro model and is a potential alternative agent for inflammatory treatment.
Keyphrases
- nuclear factor
- inflammatory response
- lps induced
- toll like receptor
- oxidative stress
- lipopolysaccharide induced
- reactive oxygen species
- signaling pathway
- induced apoptosis
- anti inflammatory
- transcription factor
- dna damage
- endothelial cells
- wound healing
- ischemia reperfusion injury
- cell death
- binding protein
- induced pluripotent stem cells
- immune response
- diabetic rats
- nitric oxide
- epithelial mesenchymal transition
- soft tissue
- endoplasmic reticulum stress
- cell proliferation
- mass spectrometry
- replacement therapy
- combination therapy
- climate change
- human health